Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Share markets slip further
Thu, 20 Nov 01:30 pm

Indian share markets widened losses in the post-noon trading session. Majority of the sectoral indices are trading in the red with consumer durables and realty stocks being the major losers. However, pharma and IT stocks are trading positive.

BSE-Sensex is down 84 points and NSE-Niftyis trading 19 points down. BSE Mid Cap is trading 0.5% down and BSE Small Cap index is trading down by 0.7%. The rupee is trading at 62.14 to the US dollar.

Most of the domestic pharma stocks are trading in the green led by Elder Pharma and Strides Acrolab. Torrent Pharma and Piramal Enterprises are among the few stocks trading in the red. As per a leading financial daily, Ranbaxy's restraining order against Dr Reddy's Laboratories and US firm Endo International for launching Astrazeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte in the US markets has been rejected. Earlier in the month, the US Food and Drug Administration had revoked the tentative approval granted to Ranbaxy for the launch of generic versions of Nexium and Valcyte due to manufacturing quality lapses at the company's plants in India. Ranbaxy stock is currently trading up by 3.4%.

Majority of the mining stocks are trading in the red with Sesa Sterlite and Gujarat NRE Coke being the biggest losers. Only Hindustan zinc is trading in the green. As per a leading financial daily, the government has issued the draft rules for the re-allocation of the coal blocks cancelled by the Supreme Court in September. The government is planning to allocate 74 of more than 200 cancelled blocks by March 2015 through a mix of auctions and allocations. As per the draft rules, central and state government-owned companies can bid for blocks even though blocks will be allotted to them. Power plants operating on imported coal will be also be eligible to participate in the coal auction. Out of the coal blocks being allotted, 42 blocks with a production capacity of 90 m tonnes are operational and 32 blocks with capacity of 120 m tonnes are ready to be mined. The government does not want to increase the electricity tariffs for power generated from coal mined from these blocks.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Share markets slip further". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.